Coherus Biosciences: Funding, Investors & Team (Oct 2026)
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
Coherus Biosciences has raised $200M across 3 funding rounds on record, the most recent an undisclosed round of $50.1M announced in Feb 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Coherus Biosciences Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Coherus Biosciences Funding Rounds
Coherus Biosciences raised $100M in a Post-IPO Debt announced in Jan 2022.
1.3 years later, an undisclosed round of $50.0M was announced in May 2023.
2.8 years later, an undisclosed round of $50.1M was announced in Feb 2026.
Coherus Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Coherus Biosciences Funding Compared to Other Biotechnology Startups
Coherus Biosciences' latest round of $50.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Coherus Biosciences in Biotechnology and Redwood City
Companies Similar to Coherus Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Coherus Biosciences Funding FAQs
What does Coherus Biosciences do?
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
How much funding has Coherus Biosciences raised?
Coherus Biosciences has raised $200M across 3 rounds on record. The most recent is an undisclosed round of $50.1M announced in Feb 2026.
When did Coherus Biosciences last raise funding?
Coherus Biosciences' most recent funding round on record is an undisclosed round of $50.1M, announced in Feb 2026.
Who is the CEO of Coherus Biosciences?
Dennis Lanfear is listed as CEO at Coherus Biosciences.
Where is Coherus Biosciences headquartered?
Coherus Biosciences is based in Redwood City, California, United States.
How many employees does Coherus Biosciences have?
Coherus Biosciences is in the 251-500 employee band.
How does Coherus Biosciences' funding compare to other Biotechnology startups?
Coherus Biosciences' latest round of $50.1M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Coherus Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Coherus Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.